Back to Search
JACOB BAGLEY, M.D.
M.D.
Neurological Surgery Physician
NPI: 1447678172IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
A179465(CA)81849(WI)
Neuroradiology Physician
Radiology — Neuroradiology
Code: 2085N0700X
MD205373(OR)
CMS Specialties
PrimaryNEUROSURGERY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.
PMID 18679630·Methods Mol Biol·2008
7-preclinical
Adult neurogenesis and specific replacement of interneuron subtypes in the mouse main olfactory bulb.
PMID 17996088·BMC Neurosci·2007
7-preclinical
New approaches to the prevention of organ allograft rejection and tolerance induction.
PMID 17632412·Transplantation·2007
7-preclinical
Regulation of oxidative stress responses by ataxia-telangiectasia mutated is required for T cell proliferation.
PMID 17404255·J Immunol·2007
7-preclinical
Gene therapy progress and prospects: gene therapy in organ transplantation.
PMID 12692588·Gene Ther·2003
6-review
T cells mediate resistance to genetically modified bone marrow in lethally irradiated recipients.
PMID 12451248·Transplantation·2002
7-preclinical
Tracking and selection of retrovirally transduced murine bone marrow cells using green fluorescent protein.
PMID 12136766·Methods Mol Biol·2002
7-preclinical
Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy.
PMID 12036867·Blood·2002
7-preclinical
Establishing immunological tolerance through the induction of molecular chimerism.
PMID 11991829·Front Biosci·2002
6-review
Defining the requirements for peptide recognition in gene therapy-induced T cell tolerance.
PMID 11046007·J Immunol·2000
7-preclinical
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.
PMID 18523282·J Immunol·2008
7-preclinical
Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.
PMID 18280792·Clin Immunol·2008
7-preclinical
Activated polymorphonuclear cells promote injury and excitability of dorsal root ganglia neurons.
PMID 18201702·Exp Neurol·2008
7-preclinical
Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
PMID 17982066·J Immunol·2007
7-preclinical
Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion.
PMID 17617856·Am J Transplant·2007
7-preclinical
Long-term survival of transplanted allogeneic cells engineered to express a T cell chemorepellent.
PMID 17264814·Transplantation·2007
7-preclinical
Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells.
PMID 16827788·Am J Transplant·2006
7-preclinical
Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
PMID 16341058·Gene Ther·2006
7-preclinical
Analysis of a spindle pole body mutant reveals a defect in biorientation and illuminates spindle forces.
PMID 15525672·Mol Biol Cell·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3181 SW SAM JACKSON PARK RD, OHSU
PORTLAND, OR 97239 - Phone
- (503) 494-8211
Quick Facts
- NPI
- 1447678172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile